Tiger Brokers

BUZZ-Monte Rosa rises as heart drug shows promise in early-stage trial

Reuters
Jan 07
BUZZ-Monte Rosa rises as heart drug shows promise in early-stage trial

** Shares of drug developer Monte Rosa Therapeutics GLUE.O rise 18.6% to $19 premarket

** Co says its experimental pill, MRT-8102, sharply lowered inflammation in people at risk for heart disease in an early-stage trial

** Co's MRT-8102 cut inflammation marker CRP by 85% in high-risk patients, says co

** CRP is linked to heart disease; nearly all participants reached safe levels after 4 weeks - GLUE

** Co says study enrolled 24 people with obesity and elevated CRP; drug worked across all doses

** Co plans larger trial in patients with clogged arteries later this year - GLUE

** As of last close, stock up ~2% over the past year

(Reporting by Sahil Pandey in Bengaluru)

((Sahil.Pandey@thomsonreuters.com))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10